ADIAL PHARMACEUTICALS, INC. (ADIL) — Institutional Holders, Q2 2026
18 institutional investment managers reported a ADIL position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.9M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
ADIL in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- Stonepine Capital ManagementNew · +727,563 sh+$1.9M
- JANE STREET GROUPNew · +32,119 sh+$82.2K
- CITADEL ADVISORSNew · +29,547 sh+$75.6K
- StoneX GroupNew · +19,699 sh+$50.4K
- UBS Group AGAdded · +18,605 sh+$47.6K
Biggest sellers
- GEODE CAPITAL MANAGEMENTTrimmed · -11,856 sh-$30.4K
- BlackRockTrimmed · -806 sh-$2.1K
- Caitong International Asset Management , LtdSold out · -15 sh-$38.00
- NORTHWESTERN MUTUAL WEALTH MANAGEMENTSold out · -4 sh-$10.00
ADIL 13F holders ranked 1–18 of 18
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Stonepine Capital Management#1 · 727,563 sh | 727,563 | $1.6M | 0.74% | New |
| 2 | JANE STREET GROUP#2 · 32,119 sh | 32,119 | $82.2K | 0.00% | New |
| 3 | CITADEL ADVISORS#3 · 29,547 sh | 29,547 | $75.6K | 0.00% | New |
| 4 | UBS Group AG#4 · 19,147 sh | 19,147 | $49.0K | 0.00% | +3432.7% |
| 5 | StoneX Group#5 · 19,699 sh | 19,699 | $35.7K | <0.01% | New |
| 6 | GEODE CAPITAL MANAGEMENT#6 · 12,393 sh | 12,393 | $31.7K | 0.00% | -48.9% |
| 7 | China Universal Asset Management , Ltd.#7 · 8,000 sh | 8,000 | $20.5K | <0.01% | New |
| 8 | VANGUARD FIDUCIARY#8 · 5,879 sh | 5,879 | $15.1K | 0.00% | 0.0% |
| 9 | VANGUARD CAPITAL MANAGEMENT#9 · 5,831 sh | 5,831 | $14.9K | 0.00% | +1515.2% |
| 10 | Manchester Capital Management#10 · 1,923 sh | 1,923 | $4.9K | — | 0.0% |
| 11 | Tower Research Capital (TRC)#11 · 1,419 sh | 1,419 | $3.6K | <0.01% | +4.6% |
| 12 | BlackRock#12 · 304 sh | 304 | $778.00 | 0.00% | -72.6% |
| 13 | RAFFA WEALTH MANAGEMENT#13 · 83 sh | 83 | $212.00 | 0.00% | 0.0% |
| 14 | MORGAN STANLEY#14 · 50 sh | 50 | $128.00 | 0.00% | 0.0% |
| 15 | SBI Securities , Ltd.#15 · 47 sh | 47 | $120.00 | — | 0.0% |
| 16 | WELLS FARGO & COMPANY#16 · 6 sh | 6 | $15.00 | 0.00% | 0.0% |
| 17 | HARBOUR INVESTMENTS#17 · 3 sh | 3 | $8.00 | 0.00% | 0.0% |
| 18 | Abound Wealth Management#18 · 1 sh | 1 | $3.00 | — | 0.0% |
Funds that sold out of ADIL in Q2 2026 (2)
Held ADIL at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| Caitong International Asset Management , Ltd15 sh | 15 | $27.00 |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT4 sh | 4 | $7.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.